Clinical Trial Update: Hypofractionated Partial Breast Irradiation in Treating Patients With Early Stage Breast Cancer [Phase 2, Phase 3]

View source ↗

Summary

A phase 2/3 clinical trial evaluating hypofractionated partial breast irradiation for early-stage breast cancer has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Ductal Breast Carcinoma In Situ, Early-Stage Breast Carcinoma | Phase 2, Phase 3 | Status: SUSPENDED